Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06344325
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-03-26
Brief Title:
ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Study Overview
Official Title:
90 Effective Dose Study of Fospropofol Disodium in Induction and Maintenance of Anesthesia in Adults of Different Ages
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Exploring the 90 effective dose ED90 of fospropofol disodium in induction and maintenance of anesthesia in adults of different ages providing more clinical evidence for the application of fospropofol disodium in clinical anesthesia
Detailed Description:
As a newly marketed sedative hypnotic agent fospropofol disodium is currently the only water-soluble precursor drug of propofol in China It has the characteristics of long duration of action low incidence of injection pain respiratory and circulatory system related adverse events and no lipid metabolism related adverse reactions providing anesthesiologists with another sedative option during surgery However there are currently few clinical observation studies on this drug and there have been no reports on its effective dosage in different age groups Therefore this study aims to observe the 90 effective dose ED90 in anesthesia induction and maintenance in adults of different ages providing effective clinical evidence for its application in clinical anesthesia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None